Chemical Compound

Galeterone

CAS Registry Number 851983-85-2
Galeterone chemical structure
Primary Record

Galeterone

In stock
9,063 g
Purity
98.9 %
CAS
851983-85-2

Compound Identifiers & Properties

CAS
851983-85-2
PubChem CID
11188409
SMILES
C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4N5C=NC6=CC=CC=C65)C)O
Canonical SMILES
C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12

Names & Synonyms

  • Galeterone
  • Galaterone
  • TOK-001
  • 851983-85-2
  • galeterona
  • galeteronum
  • Geleterone
  • Galeterone [USAN]
  • TOK 001
  • Galeterone (USAN)
  • Galeterone Impurity 1
  • Tok-001 (galeterone)
  • Galeterone [USAN:INN]
  • TOK-001(Galeterone)
  • TOK-001; Galeterone
  • GALETERONE [INN]
  • VN/124-1
  • RefChem:142163
  • UNII-WA33E149SW
  • WA33E149SW
  • TOK-OO1
  • TOK-001(Galeterone)?
  • VN/124
  • D0U0BU
  • C26H32N2O
  • CPD-1
  • GALETERONE [WHO-DD]
  • cc-264
  • SCHEMBL939234
  • MFCD16660907
  • VN 124
  • VN-124
  • DTXSID101025602
  • GTPL8638
  • orb1300706
  • CHEMBL2105738
  • Galeterone, >=98% (HPLC)
  • SCHEMBL29350724
  • CHEBI:177536
  • PAFKTGFSEFKSQG-PAASFTFBSA-N
  • BCPP000040
  • DTXCID801509865
  • AMY27882
  • BCP02827
  • EX-A1025
  • TOK-001/
  • ZINC6718442
  • ABP000369
  • BDBM50435990
  • VN-124-1
  • AKOS005146524
  • CM11049
  • CS-0334
  • DB12415
  • FT65187
  • NX41765
  • RL05280
  • TOK-001;VN-124-1
  • CID11188409
  • AC-26549
  • AS-56204
  • CID 11188409
  • CID:11188409
  • HY-70006
  • SC-96681
  • SID:53789573
  • 3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene
  • A8623
  • FT-0774426
  • NS00070343
  • Y0281
  • (3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol
  • 17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3beta-ol
  • J2.952.671K
  • Benzene,1,3,5-tris(3,3-dimethyl-1-butynyl)
  • D10125
  • W-5660
  • A858327
  • C500627
  • C570636
  • Q5518498
  • (3beta)-17-(1h-benzimidazol-1-yl)androsta-5,16-dien-3-ol
  • 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene
  • (3S,8R,9S,10R,13S,14S)-17-(1H-Benzo[d]imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
  • (3?)-17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3-ol
  • 17-(1H-Benzoimidazole-1-yl)androsta-5,16-diene-3beta-ol
  • Androsta-5,16-dien-3-ol, 17-(1H-benzimidazol-1-yl)-, (3beta)-
  • B0084-251227
  • VN/124-1;TOK-001;VN 124;TOK001;TOK 001
  • 17-(1H-Benzoimidazole-1-yl)-androsta-5,16-diene-3beta-ol
  • 3beta-Hydroxy-17-(1H-benzimidazol-1-yl)-androsta-5,16-diene
  • 3beta-Hydroxy-17-(1H-benzimidazol-1-yl)androsta-5,16-diene
  • 3beta-Hydroxy-17-(1H-benzoimidazole-1-yl)androsta-5,16-diene
  • Specific Androgen Receptor Modulator/CYP17 Lyase Inhibitor TOK-001
  • (3alpha,8alpha)-17-(1h-Benzimidazol-1-Yl)androsta-5,16-Dien-3-Ol
  • ANDROSTA-5,16-DIEN-3-OL, 17-(1H-BENZIMIDAZOL-1-YL)-, (3.BETA.)-
  • (1S,2R,5S,10R,11S,15S)-14-(1H-1,3-benzodiazol-1-yl)-2,15-dimethyltetracyclo(8.7.0.02,?.011,1?)heptadeca-7,13-dien-5-ol
  • (3aS,3bR,7S,9aR,9bS,11aS)-1-(1H-1,3-benzodiazol-1-yl)-9a,11a-dimethyl-3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol
  • (3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta(a)phenanthren-3-ol
  • 2061-71-4
  • 8-hydroxy-10a,12a-dimethyl-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydronaphtho[2,1-f]chromen-2-one